The value of antinuclear antibody testing and retesting.
Publication
, Journal Article
Pisetsky, DS
Published in: Lancet Rheumatol
July 2020
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Lancet Rheumatol
DOI
EISSN
2665-9913
Publication Date
July 2020
Volume
2
Issue
7
Start / End Page
e373 / e374
Location
England
Related Subject Headings
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Pisetsky, D. S. (2020). The value of antinuclear antibody testing and retesting. Lancet Rheumatol, 2(7), e373–e374. https://doi.org/10.1016/S2665-9913(20)30097-7
Pisetsky, David S. “The value of antinuclear antibody testing and retesting.” Lancet Rheumatol 2, no. 7 (July 2020): e373–74. https://doi.org/10.1016/S2665-9913(20)30097-7.
Pisetsky DS. The value of antinuclear antibody testing and retesting. Lancet Rheumatol. 2020 Jul;2(7):e373–4.
Pisetsky, David S. “The value of antinuclear antibody testing and retesting.” Lancet Rheumatol, vol. 2, no. 7, July 2020, pp. e373–74. Pubmed, doi:10.1016/S2665-9913(20)30097-7.
Pisetsky DS. The value of antinuclear antibody testing and retesting. Lancet Rheumatol. 2020 Jul;2(7):e373–e374.
Published In
Lancet Rheumatol
DOI
EISSN
2665-9913
Publication Date
July 2020
Volume
2
Issue
7
Start / End Page
e373 / e374
Location
England
Related Subject Headings
- 3202 Clinical sciences